Trial Profile
A Randomized, Double-blind, Placebo-controlled, Single Intravenous Ascending Dose Study of E3112 in Japanese Healthy Adult Male Subjects
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 23 Nov 2018
Price :
$35
*
At a glance
- Drugs E 3112 (Primary)
- Indications Unspecified
- Focus Adverse reactions; Pharmacokinetics
- Sponsors EA Pharma
- 28 Aug 2018 Status changed from active, no longer recruiting to completed.
- 14 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 07 Sep 2017 Planned End Date changed from 1 Oct 2017 to 1 Oct 2018.